This inventor holds 2 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Genfit. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: Emilie Praca: Innovator in Non-Alcoholic Steatohepatitis Diagnostics
Introduction
Emilie Praca is a prominent inventor based in Lille, France. She has made significant contributions to the field of medical diagnostics, particularly in the area of non-alcoholic steatohepatitis (NASH). With a total of 2 patents, her work is paving the way for innovative approaches to diagnosing and treating this condition.
Latest Patents
Emilie Praca's latest patents focus on non-invasive diagnostic methods for NASH. The first patent describes a novel method for diagnosing NASH and classifying subjects as potential candidates for treatment. The second patent outlines methods for diagnosing and evaluating NASH, utilizing circulating miRNAs and other blood markers of liver damage. This includes markers such as alpha 2 macroglobulin, HbA1c, and specific miRNAs. Additionally, her patents include a kit designed for implementing these diagnostic methods, along with compounds for treating NASH.
Career Highlights
Emilie Praca is currently associated with Genfit, a company dedicated to developing innovative solutions for liver diseases. Her work at Genfit has been instrumental in advancing the understanding and treatment of NASH.
Collaborations
Emilie collaborates with notable colleagues, including Raphaël Darteil and John Brozek. Their combined expertise contributes to the innovative research and development efforts at Genfit.
Conclusion
Emilie Praca's contributions to the field of non-alcoholic steatohepatitis diagnostics highlight her role as a leading inventor in medical innovation. Her patents represent a significant advancement in the diagnosis and treatment of liver diseases.